Gastric cancer is a leading cause of cancer-related deaths in Central America, where Helicobacter pylori infection is highly prevalent.
This study aimed to assess the association between regular use of aspirin (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of gastric adenocarcinoma in this high-incidence region.
